Overall survival (OS) in 253 patients with multiple myeloma... | Download Scientific Diagram
Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
Progression-free and overall survival for high-risk patients with relapsed or refractory multiple myeloma (RRMM) who received carfilzomib-based regimens
Frontiers | Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance
Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience | Cancer Communications | Full Text
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome | Blood Cancer Journal
Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients | PLOS ONE
Duration of Survival in Patients with Myeloma Treated with Thalidomide | NEJM
Overall survival of 3664 patients with multiple myeloma, according to... | Download Scientific Diagram
Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France
Trends in the multiple myeloma treatment landscape and survival: a U.S. analysis using 2011–2019 oncology clinic electronic he
Trends in overall survival and costs of multiple myeloma, 2000–2014 | Leukemia
Disparities in Care and Outcomes
Mayo Clinic Rochester Publishes Updated Multiple Myeloma Survival Rates! - Multiple Myeloma - Survival Rate Statistics by Hospital
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry | Haematologica
Blog Archives - Multiple Myeloma - Survival Rate Statistics by Hospital
Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes - Landgren - 2017 - Journal of Internal Medicine - Wiley Online Library
Myeloma survival statistics | Cancer Research UK
Cureus | Increased Risk of Second Primary Malignancy and Mortality at ten Years After Stem Cell Transplant for Multiple Myeloma: An Analysis of 14,532 Patients
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press
Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma - ScienceDirect
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry | Haematologica
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial - The Lancet
del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma - ScienceDirect
Retrospective analysis of 264 multiple myeloma patients
Figure 1 from Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. | Semantic Scholar
